A Study to Test the Safety of the Investigational Drug Larotrectinib in Adults That May Treat Cancer

Clinical trial NCT02122913 · COMPLETED

Trial details

NCT number: NCT02122913
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumors Harboring NTRK Fusion

Start date: 2014-05-04
Primary completion: 2017-02-01
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.